This study will help determine whether the agent UC-781, formulated as a gel, is safe when
applied to the vagina twice daily for 14 days. It will also assess whether women find the gel
acceptable to use.
Phase:
Phase 1
Details
Lead Sponsor:
CONRAD
Collaborators:
Centers for Disease Control and Prevention Emory University